DXCM - CIK 0001093557
The table below shows DEXCOM INC's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.12B | $1.84B | $1.16B | $904.90M | $621.20M | $939.20M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $1.09B | $1.11B | $1.35B | $1.16B | $1.00B | $945.20M |
| Inventory | $693.60M | $604.10M | $570.70M | $538.20M | $586.30M | $570.30M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $4.33B |
| $5.22B |
| $5.03B |
| $4.55B |
| $4.26B |
| $4.85B |
| Property, plant & equipment | - | - | - | - | - | - |
| Goodwill | $24.20M | $24.10M | $24.10M | $23.10M | $23.80M | $23.30M |
| Total assets | $6.63B | $7.50B | $7.33B | $6.75B | $6.35B | $6.80B |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | $2.22B | $3.34B | $3.31B | $3.04B | $1.73B | $1.72B |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $3.68B | $4.77B | $4.75B | $4.49B | $4.37B | $4.36B |
| Retained earnings | $2.63B | $2.17B | $1.88B | $1.70B | $1.45B | $1.31B |
| Total equity | $2.96B | $2.73B | $2.57B | $2.27B | $1.98B | $2.43B |